Aclarion Welcomes Advocate Health as CLARITY Trial Site

BROOMFIELD, Colo., May 05, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the addition of Advocate Aurora Research Institute, part of Advocate Health, as a CLARITY (Chronic Low bAck pain Randomized Independent Trial studY) site. CLARITY is a pivotal, randomized trial designed to demonstrate Nociscan’s clinical and economic value in spine surgery.

Read more at globenewswire.com